Get the Stockscreener App
0.815
1.49%
-0.0123
Bone Biologics Corp Stock (BBLG) Forecast
The Bone Biologics Corp (BBLG) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.7137, representing a -12.43% decrease from the current price of $0.815. The highest analyst price target is $0.718, and the lowest is $0.7094.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBLG Price Target
Average 2.6748
(+228.20% Upside)
Is Bone Biologics Corp (BBLG) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 36.55 | Neutral |
| STOCH(9,6) | 34.88 | Neutral |
| STOCHRSI(14) | 69.06 | Neutral |
| MACD(12,26) | -0.0597 | Sell |
| ADX(14) | 20.19 | Neutral |
| William %R | -80.39 | Buy |
| CCI(14) | -28.84 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.8304
Sell
|
0.8476
Sell
|
| MA20 |
0.9037
Sell
|
0.894
Sell
|
| MA50 |
0.9938
Sell
|
0.9914
Sell
|
| MA100 |
1.1392
Sell
|
1.13
Sell
|
| MA200 |
1.3541
Sell
|
1.3819
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, BBLG could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on BBLG, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 36.55 indicates that BBLG is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 34.88 indicates that BBLG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 69.06 indicates that BBLG is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.19 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -28.84 indicates that BBLG is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BBLG price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Bone Biologics Corp financial reports and earnings history, Bone Biologics Corp (BBLG) stock could reach $0.4319 by 2030, $10.93 by 2040 and $7.3801 by 2050. See the projected annual prices until 2050 of the Bone Biologics Corp stock below:
- Bone Biologics Corp (BBLG) is expected to reach an average price of $5.0272 in 2035, with a high prediction of $5.0727 and a low estimate of $5.0536. This indicates an $516.83% rise from the last recorded price of $0.815.
- Bone Biologics Corp (BBLG) stock is projected to chart a bullish course in 2040, with an average price target of $10.81, representing an $1,226% surge from its current level. The forecast ranges from a conservative $10.85 to a sky-high $10.93.
- Our analysts predict Bone Biologics Corp (BBLG) to jump 1,934% by 2045, soaring from $16.04 to an average price of $16.58, potentially reaching $15.88. While $16.04 is the low estimate, the potential upside is significant.
- Bone Biologics Corp (BBLG) stock is expected to climb by 2050, reaching an average of $7.6301, a $836.20% jump from its current level. However, a wide range of estimates exists, with high and low targets of $7.3801 and $7.673, respectively, highlighting the market's uncertainty.
Bone Biologics Corp Stock (BBLG) Year by Year Forecast
Bone Biologics Corp Stock (BBLG) Price Forecast for 2025
Bone Biologics Corp Stock (BBLG) is expected to reach an average price of $1.1264 in 2025, with a high prediction of $1.6131 and a low estimate of $0.6397. This indicates an +38.21% rise from the last recorded price of $0.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $0.808 | $0.7094 | $0.718 | -0.85% |
| May, 2025 | $1.4165 | $0.8577 | $0.9017 | +73.81% |
| June, 2025 | $1.5054 | $1.475 | $1.4554 | +84.71% |
| July, 2025 | $1.6038 | $1.6218 | $1.6037 | +96.79% |
| August, 2025 | $1.6524 | $1.6221 | $1.6131 | +102.75% |
| September, 2025 | $1.5248 | $1.5655 | $1.5687 | +87.09% |
| October, 2025 | $1.4194 | $1.4461 | $1.4901 | +74.16% |
| November, 2025 | $1.4698 | $1.4374 | $1.4287 | +80.34% |
| December, 2025 | $1.4354 | $1.4488 | $1.4574 | +76.12% |
Bone Biologics Corp Stock (BBLG) Price Forecast for 2026
The predicted value for Bone Biologics Corp (BBLG) in 2026 is set at an average of $4.6803. Estimates vary from a peak of $9.3176 to a trough of $0.0431, indicating an +474.27% surge from the present price of $0.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.4451 | $1.4235 | $1.3984 | +77.31% |
| February, 2026 | $1.4097 | $1.4212 | $1.4254 | +72.97% |
| March, 2026 | $0.1224 | $0.0431 | $5.3066 | -84.98% |
| April, 2026 | $0.2208 | $0.1621 | $0.2383 | -72.91% |
| May, 2026 | $0.7884 | $0.2101 | $0.6039 | -3.26% |
| June, 2026 | $0.6991 | $0.7683 | $0.7483 | -14.22% |
| July, 2026 | $0.7663 | $0.6974 | $0.7568 | -5.97% |
| August, 2026 | $0.8172 | $0.8254 | $0.8004 | +0.27% |
| September, 2026 | $0.8524 | $0.8342 | $0.8388 | +4.59% |
| October, 2026 | $3.9079 | $0.8823 | $9.3176 | +379.50% |
| November, 2026 | $2.4392 | $1.9086 | $4.0382 | +199.29% |
| December, 2026 | $1.3109 | $1.1209 | $3.5699 | +60.84% |
Bone Biologics Corp Stock (BBLG) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Bone Biologics Corp (BBLG) is $1.7136, with a high forecast of $3.0134 and a low forecast of $0.4139. This indicates an +110.26% increase from the last price of $0.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.1522 | $1.0022 | $1.9611 | +41.38% |
| February, 2027 | $0.5535 | $0.5035 | $1.2029 | -32.08% |
| March, 2027 | $1.5493 | $0.4139 | $1.9919 | +90.10% |
| April, 2027 | $1.4067 | $1.4573 | $1.3813 | +72.60% |
| May, 2027 | $1.424 | $1.4453 | $0.9953 | +74.73% |
| June, 2027 | $2.7007 | $1.5533 | $2.6207 | +231.37% |
| July, 2027 | $2.828 | $2.7687 | $2.658 | +247.00% |
| August, 2027 | $1.9354 | $2.9567 | $2.8374 | +137.47% |
| September, 2027 | $2.222 | $1.9589 | $1.8634 | +172.64% |
| October, 2027 | $3.1094 | $2.3814 | $2.4094 | +281.52% |
| November, 2027 | $2.8367 | $2.9467 | $2.8006 | +248.06% |
| December, 2027 | $3.0234 | $3.076 | $3.0134 | +270.97% |
Bone Biologics Corp Stock (BBLG) Price Forecast for 2028
In 2028, Bone Biologics Corp (BBLG) is projected to reach an average price of $3.1193, with a high projection of $3.5092 and a low estimate of $2.7294. This indicates an +282.74% rise from the last price of $0.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.9407 | $3.0207 | $2.9207 | +260.83% |
| February, 2028 | $2.7981 | $2.7294 | $2.5194 | +243.32% |
| March, 2028 | $2.8848 | $2.7874 | $2.7561 | +253.96% |
| April, 2028 | $3.4242 | $2.9941 | $3.3721 | +320.15% |
| May, 2028 | $3.5388 | $3.4731 | $3.5034 | +334.20% |
| June, 2028 | $3.4995 | $3.5051 | $3.5092 | +329.39% |
| July, 2028 | $3.4391 | $3.4783 | $3.4755 | +321.98% |
| August, 2028 | $3.2901 | $3.3101 | $3.3128 | +303.70% |
| September, 2028 | $3.2029 | $3.2053 | $3.1795 | +292.99% |
| October, 2028 | $3.175 | $3.1758 | $3.1656 | +289.57% |
| November, 2028 | $3.0515 | $3.0793 | $3.1241 | +274.41% |
| December, 2028 | $3.0503 | $3.087 | $3.0438 | +274.27% |
Bone Biologics Corp Stock (BBLG) Price Forecast for 2029
The 2029 price forecast for Bone Biologics Corp Stock (BBLG) is $4.0467 on average, with a high prediction of $8.0751 and a low estimate of $0.0182. This represents an +396.52% increase from the previous price of $0.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.6055 | $1.6162 | $3.7232 | +96.99% |
| February, 2029 | $1.5928 | $1.7042 | $1.5942 | +95.44% |
| March, 2029 | $1.6802 | $1.6902 | $1.6615 | +106.16% |
| April, 2029 | $2.2069 | $2.1885 | $2.187 | +170.79% |
| May, 2029 | $2.1843 | $2.0949 | $2.1064 | +168.01% |
| June, 2029 | $2.1665 | $2.1565 | $2.1461 | +165.83% |
| July, 2029 | $2.1278 | $2.1387 | $2.1309 | +161.08% |
| August, 2029 | $0.7945 | $2.135 | $2.1225 | -2.52% |
| September, 2029 | $0.8271 | $0.5652 | $8.0751 | +1.49% |
| October, 2029 | $1.5554 | $0.5199 | $2.3998 | +90.85% |
| November, 2029 | $0.1731 | $0.0182 | $2.1911 | -78.76% |
| December, 2029 | $0.4242 | $0.0838 | $0.5138 | -47.95% |
Bone Biologics Corp Stock (BBLG) Price Forecast for 2030
Bone Biologics Corp Stock (BBLG) is expected to reach an average price of $2.8535 in 2030, with a high forecast of $5.206 and a low forecast of $0.5009. This signifies an +250.12% surge from the last price of $0.815.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.4664 | $0.5009 | $0.4319 | -42.77% |
| February, 2030 | $3.552 | $3.6282 | $3.2841 | +335.83% |
| March, 2030 | $3.908 | $3.938 | $3.488 | +379.51% |
| April, 2030 | $3.8539 | $3.957 | $3.635 | +372.87% |
| May, 2030 | $5.009 | $4.573 | $5.041 | +514.61% |
| June, 2030 | $5.315 | $5.158 | $5.206 | +552.15% |
| July, 2030 | $4.3201 | $4.276 | $4.8413 | +430.07% |
| August, 2030 | $4.6161 | $4.3591 | $4.4961 | +466.39% |
| September, 2030 | $5.0421 | $4.8851 | $4.9451 | +518.66% |
| October, 2030 | $4.8907 | $5.1501 | $5.0714 | +500.09% |
| November, 2030 | $5.2047 | $5.2241 | $5.1651 | +538.61% |
| December, 2030 | $4.7291 | $4.8191 | $5.0311 | +480.26% |
0.57%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):